You cannot apply for this job anymore (deadline was 31 Jan 2022).
Browse the current job offers or choose an item in the top navigation above.
The successful candidate will be part of our team that critically assesses HTA models submitted to NICE (UK). These models are designed to evaluate the cost-effectiveness of various types of health care interventions, ranging from new drugs to diagnostics and medical devices. Besides this, time may be spent on designing and programming new models (both for commercial and non-commercial clients). The work may require travel abroad.
They may also work on methodological improvements in modelling, for example in the context of European or ZonMW projects, and advise fellow researchers with respect to e.g. statistical aspects of their research.
Furthermore, the post-doc may be involved in the education of bachelor and master students with respect to advanced research methods and health economic modelling.
PhDs in health economics, economics, statistics, operations research, or closely related quantitative discipline with:
We offer internationally-oriented and varied work within an enthusiastic team, with attractive fringe benefits in accordance with the Collective Labour Agreement for Dutch Universities (CAO-NU). We offer a full-time contract, initially for one year with possible extension to four years, as post-doc at EUR. Your salary will depend on prior experience and degrees obtained and will be calculated on the basis of full-time salary (38 hours per week) ranging between € 3.821,- and € 5.943,- gross per month (salary scale 11 or 12, CAO NU). Erasmus University Rotterdam offers attractive terms of employment, including a holiday allowance of 8%, a year-end payment of 8.3%, and 232 hours paid vacation per year based on a full-time appointment. In addition, EUR takes part in the ABP pension scheme, and we also offer partially paid parental leave.
The Erasmus University Rotterdam (EUR), named after Rotterdam-born humanist and theologian Erasmus, is a research university with a strong international orientation and a pronounced social focus, both in its education and research activities. On the lively, modern campus, more than 28.000 students and scholars of more than 100 nationalities are constantly encouraged to develop their talents and meet their ambition. Our more than 2.700 scientists and employees work together with all our students to solve challenges faced by global society, drawing their inspiration from the consistently dynamic and cosmopolitan city of Rotterdam. The academic education offered at our faculties is intensive, engaging and strongly focused on practical application. We increasingly perform our research in multidisciplinary teams, which are closely interwoven with international networks. In terms of research impact and the quality of its degree programmes, EUR can compete with the foremost universities in Europe, which is reflected in its consistent top-100 position in most major universities rankings. Erasmus University Rotterdam’s key values are daring, curiosity, social involvement, breaking new ground and striving for success www.eur.nl
Erasmus School of Health Policy & Management (ESHPM) is part of Erasmus University Rotterdam (EUR) and linked with Erasmus MC. ESHPM is responsible for several education programmes on policy, management and economics in health care, which serve around 1000 students yearly. In addition, it is also very active in research, which can be divided into three major themes: ‘Competition and Regulation in Health Care’, ‘Quality and Efficiency in Health Care’ and ‘Health Care Management’. ESHPM has about 175 employees.
We are looking for a post-doc within the section Health Technology Assessment (HTA), a section that is recognized for their independent and excellent research in HTA, health economics and health outcomes research.
Health Technology Assessment - our projects
The main goal of HTA is estimating the value of innovations in health care. Our department contributes to important and influential methodological innovations. It is dedicated to stimulating the use of cost-effectiveness information in healthcare decision making. This requires that evidence about effectiveness and costs from various different sources is synthesized into probabilistic decision-analytic models. Our section HTA has a large and experienced team of modellers who develop and implement such models. This work is often funded by policy makers or manufacturers to inform reimbursement decisions. Examples are the technology appraisals that are conducted by the section HTA for the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom and the National Health Care Institute (ZIN) in the Netherlands.
We maken het je graag makkelijk, log in voor deze en andere handige functies: